Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 5, 2006
Grant Date -
Dec 5, 2002
app pub date -
Dec 13, 2001
filing date -
Jun 16, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention concerns pharmaceutical compositions with wound healing or anti-complementary activity, and their uses, said compositions comprising, (1) at least a dextran derivative of general formula DMC.sub.aB.sub.bSu.sub.c, a, b, and c respectively representing the degrees of substitution in the groups MC, B and Su, wherein a.gtoreq.0.6, b=0 or .gtoreq.0.1, and c=0 or ranges widely between 0.1 and 0.5 for a wound healing composition, and a.gtoreq.0.3, b.gtoreq.0.1 and c=0 or ranges widely between 0.1 and 0.4 for a composition with anti-complementary activity; (2) and at least a pharmaceutically acceptable carrier, said dextran derivative being present in a single unit dose or at a concentration adapted to the desired wound healing or anti-complementary activity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully